INJ: Meridian is approaching execution; the event position can participate, but it cannot replace the core position.

Data as of September 21, 2026.
Start with the conclusion.
IIP-701 Meridian is the most important short-term event in this cycle. External coverage indicates about 99% support; users have authorized to pass it with high probability through the relevant processing. However, the official governance interface still currently shows the voting period, and the final voting receipt still needs confirmation. The v1.20.4 binary has been released. The target is to execute at block 184394000 on September 24. Current price is about $7.836. The event position can participate, but you should not treat the upgrade expectation as the core thesis for the main position.
The cap for the event position is 20% of the planned total amount, with no leverage. The first 10% is entered at $7.45–$7.70. The second 10% is entered only after the upgrade is completed, the chain is stable, and it has held above $7.85 for 4 hours. Stop loss at $7.25; take profit in stages at $8.20, $8.80, and $9.50–$9.80. If within 24–72 hours after the upgrade there is no real RWA, MultiVM, RFQ activity, or fee growth, exit the remaining event position.
The project progress has not been distorted, but the value feedback loop is not yet complete
Injective is not a single trading page; it is a chain built for financial applications. It combines on-chain order books, spot and derivatives, oracles, cross-chain functionality, the WASM and EVM execution environments, and RWA tooling together—so developers can avoid doing another layer of basic infrastructure work. For traders, market makers, developers of financial applications, and asset issuers, this kind of modularity is indeed valuable.
The problem is that having a product does not mean the token has already received the same value. Meridian puts compliant RWA standards, the MultiVM market, private RFQ testing, market risk controls, and oracle improvements into a single upgrade. What it solves is the institutional onboarding barrier—not directly creating issuer activity, trading volume, or protocol revenue. RWA, stablecoins, and institutional trading are still upside options; they cannot be priced based on realized revenue.
Operating data: trades are growing, but fees remain very small
Current TVL is about $13.83 million. DEX trading over the past 30 days is about $199.7 million, and trading growth over the past 7 days is about 49%. Protocol fees over the past 30 days are about $9,047. Although weekly fees are still rising, their absolute scale is extremely small compared to a market cap of about $772 million.
This set of data indicates at least two things. First, Injective does have real activity—its trading infrastructure is still being used. Second, the price the market is giving is more like an option to buy future financial activity, rather than buying today’s cash flows. Next, we must see whether trade growth can continue to convert into fees, not just whether trade volume or announcement counts rise.
Fee adjustments also have a double-edged nature. Lower trading costs help attract traders, but if trading volume cannot expand enough to offset the fee-rate decline, protocol revenue and buyback capital will be under pressure instead. The truly meaningful indicators are continuous trends in fees, buybacks, and burn.
Token model: no traditional unlocks does not mean a fixed supply
Injective’s genesis allocation and its unlock have already been completed. There is no typical cliff for team, advisors, or private sales unlocks in the future—this is an advantage over many low-float tokens. However, on-chain Mint parameters show current inflation of 4.4%, with annualized block rewards of about 5.41 million INJ. The target staking rate is 60%. Therefore, the core supply-side risk has shifted from “a huge unlock on some day” to “whether ongoing issuance is covered by burns.”
Community BuyBack and other burn mechanisms connect ecosystem revenue with INJ supply, which is a stronger value-capture design than governance rights alone. However, cumulative burns only show that burning has happened in the past; they cannot prove that the system is currently net deflationary. If annual issuance is about 5.41 million while continuous buybacks are only on the order of hundreds of thousands, then supply is still increasing net.
This means INJ’s deflationary premium must be discounted. Scarcity will only move from narrative to a verifiable outcome when the monthly buyback scale keeps expanding and actual burns approach or exceed block rewards.
Competitive position: there is modular differentiation, but the liquidity network is not deep enough
What Injective faces is not just a single competitor. Hyperliquid is stronger in professional trading and derivative liquidity, dYdX occupies the professional derivatives brand position, Solana and Sui have a larger developer and asset distribution network, and centralized exchanges have deeper spot liquidity and compliant entry points.
Injective’s advantages lie in integrated financial modules, low costs, the ability to combine an order book with MultiVM. Its weaknesses are that TVL, fees, and revenue that can be independently attributed are still small, and the migration costs for traders and issuers are not high enough to create lock-in. It is more like a chance to become a leading second-tier infrastructure for financial applications, rather than a settlement layer that has already established monopoly.
Valuation and actions
In the conservative scenario, it is $3.20—corresponding to RWA and institutional growth not being realized, fees staying sluggish, and issuance continuing to exceed burns. In the base scenario, it is $6.00—corresponding to trading activity staying steady, with EVM and RWA bringing modest incremental effects, but fees still unable to fully cover issuance. In the optimistic scenario, it is $12.50—corresponding to institutional assets, derivatives, and stablecoins forming repeat payments, with buybacks and burns expanding continuously.
The current price has already priced in part of the expectation of successful upgrades, so the event tranche must be managed separately. $7.45–$7.70 only allows the first 10% participation; do not chase above $8.35. If, after the upgrade, the price holds above $7.85, then consider the second 10%. $7.25 is the hard stop-loss. Scale out in segments at $8.20, $8.80, and $9.50–$9.80. If the event tranche sees no real usage and fee validation within 24–72 hours after the upgrade, it automatically ends.
Do not add to existing positions near $7.836. If the price keeps rising but fees and net supply do not improve in tandem, reduce overly heavy exposure during any rebound. If the 30-day fees, DEX trades, and TVL decline synchronously, or if a security incident occurs that causes permanent loss, cancel all unexecuted tranches.
Next step: only look at these data
First, the official final voting results and the execution of the upgrade. Second, whether the chain stabilizes and recovers after the target block. Third, whether there are real compliant RWA issuers, MultiVM trading counterparties, and private RFQ participants. Fourth, whether the fees and INJ usage increase over the past 30 days. Fifth, whether the actual burn amount from the Community BuyBack can approach annualized incremental additions.
Injective’s long-term opportunity still exists, but the most important fact right now is this: the technology roadmap is expanding, while the token value feedback loop has not yet caught up.
$INJ